Top news of the week: 25.02.2020.

#BioTech #carmat #Paris #health #HealthCare #artificialintelligence

Healthcare

On Feb 19, 2020
@JNap5C shared
RT @adamfeuerstein: Frank Reynolds, founder of Medford biotech who defrauded investors of $7.5m gets 7 years in prison https://t.co/shtCnBddKg
Open

Founder of Medford biotech who defrauded investors of $7.5m gets 7 years in prison

Founder of Medford biotech who defrauded investors of $7.5m gets 7 years in prison

Frank Reynolds had said his company’s painkiller would replace opioids.

On Feb 24, 2020
@matthewherper shared
A Chinese biotech partners with GSK to boost its coronavirus vaccine development by ⁦@DrewQJoseph⁩ https://t.co/ObFYZb6deU
Open

A Chinese biotech partners with GSK to boost its coronavirus vaccine development

A Chinese biotech partners with GSK to boost its coronavirus vaccine development

A Chinese biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform as it works to develop a product that can stop infection from the novel coronavirus, the ...

On Feb 19, 2020
@BiotechSweden shared
RT @novanexia: Meet 15 of the most successful #biotech companies in #Paris 🇫🇷👍 👉https://t.co/NliuYYsgoT 🧬@cellectis @DBVTechnologies @GenSightBio @EnteromeSA @Abivax_ @GlobalBioenergi @Nanobiotix @OSEIMMUNO #carmat @DNAScript @tissiumtech @Pharnext @LYSOGENE @MedDayPharm @Onxeo_ 🧬 https://t.co/JwgYtahB4G
Open

Get to Know 15 Awesome Biotechs in Paris

Get to Know 15 Awesome Biotechs in Paris

Paris attracts millions of tourists to see some of the world’s most iconic monuments: the Eiffel Tower, the Louvre, the Arc de Triomphe … but it also attracts a lot of biotechs. Here are 15 ...

On Feb 18, 2020
@BiotechSweden shared
Chutes & Ladders—Ex-Pfizer R&D head Abraham joins Vividion https://t.co/AqJPkq5LuL https://t.co/LjuNDDxClY
Open

Chutes & Ladders—Ex-Pfizer R&D head Abraham joins Vividion

Chutes & Ladders—Ex-Pfizer R&D head Abraham joins Vividion

Vividion nabs ex-Pfizer R&D head Abraham; Lu takes CMO role at Pharvaris; Enterprise taps Morris as medical head.

On Feb 22, 2020
@BiotechSweden shared
BioMarin gene therapy won't need an AdComm as it nabs speedy FDA review https://t.co/U8Sun5Lr0P
Open

BioMarin gene therapy won't need an AdComm as it nabs speedy FDA review

BioMarin gene therapy won't need an AdComm as it nabs speedy FDA review

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval for the first gene therapy for the bleeding disease.

On Feb 18, 2020
@BiotechSweden shared
RT @CrMazars: Warren Buffett gets a double take as the investment powerhouse settles on its first biotech investment - https://t.co/bhyNcyv0jf
Open

Warren Buffett gets a double take as the investment powerhouse settles on its first biotech investment

Warren Buffett gets a double take as the investment powerhouse settles on its first biotech investment

Coke. American-Express. Apple. And Biogen? Warren Buffett’s Berkshire Hathaway, which made itself into a symbol of rock-solid investment strategy, has revealed a stake in the big biotech as ...

On Feb 23, 2020
@BiotechSweden shared
Chutes & Ladders—Scholefield out as Merck & Co. digital head https://t.co/G2sfDwNcKi https://t.co/JMDccrSz7v
Open

Chutes & Ladders—Scholefield out as Merck & Co. digital head

Chutes & Ladders—Scholefield out as Merck & Co. digital head

Merck & Co. digital head Scholefield bolts for Marriott; Endo replaces CEO Campanelli; BMS vet Quigley joins Gilead.

On Feb 24, 2020
@BiotechSweden shared
Artificial intelligence yields new antibiotic #HealthCare #artificialintelligence #health via https://t.co/2sI0UxJbpn https://t.co/nnqahDIQbV
Open

Artificial intelligence yields new antibiotic

Artificial intelligence yields new antibiotic

A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.